About the Authors

Susan L. Hills

shills@cdc.gov

Affiliation Arboviral Diseases Branch, Division of Vector-Borne Diseases, US Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

Huong Minh Vu

Affiliation Independent Expert, Ha Noi, Viet Nam

Punnee Pitisuttithum

Affiliation Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

Chang-Kweng Lim

Affiliation Laboratory of Arboviruses, Department of Virology 1, National Institute of Infectious Diseases, Japan Institute of Health Security, Tokyo, Japan

Christin H. Goodman

Affiliation Arboviral Diseases Branch, Division of Vector-Borne Diseases, US Centers for Disease Control and Prevention, Fort Collins, Colorado, United States of America

Joachim Hombach

Affiliation Independent Expert, Geneva, Switzerland

Tom Solomon

Affiliations The Pandemic Institute and the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, United Kingdom, Walton Centre NHS Foundation Trust (a Member of Liverpool Health Partners), Liverpool, United Kingdom

Competing Interests

These authors have declared that no competing interests exist: SLH, HMV, PP, CKL, CHG, JH. I have read the journal’s policy and TS has the following competing interests: TS is Director of The Pandemic Institute which has received funding from Innova, CSL Seqirus, Aviva, and AstraZeneca (since September 2021). He participated in a CME Lunch Symposium titled “Arboviral Threats Ahead: Addressing the Global Rise of Chikungunya and Japanese Encephalitis in the Age of Travel and Climate Change” which was supported by an independent medical education grant from Valneva at the Conference of the International Society of Travel Medicine (2025); this work was unpaid. He chaired the Siemens Healthineers Clinical Advisory Board (2018–2019) which was paid work. All paid work was paid to the University of Liverpool.